These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 9133940)

  • 1. Clinical features in patients with permanent visual loss due to biopsy-proven giant cell arteritis.
    Font C; Cid MC; Coll-Vinent B; López-Soto A; Grau JM
    Br J Rheumatol; 1997 Feb; 36(2):251-4. PubMed ID: 9133940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Giant cell arteritis and blindness.
    Sochocky S
    Am Fam Physician; 1977 Sep; 16(3):120-1. PubMed ID: 899999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Giant cell arteritis and polymyalgia rheumatica. Review for the otolaryngologist.
    Ferguson BJ; Allen NB; Farmer JC
    Ann Otol Rhinol Laryngol; 1987; 96(4):373-9. PubMed ID: 3619280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of clinical features and glucocorticoids on biopsy findings in giant cell arteritis.
    Jakobsson K; Jacobsson L; Mohammad AJ; Nilsson JÅ; Warrington K; Matteson EL; Turesson C
    BMC Musculoskelet Disord; 2016 Aug; 17(1):363. PubMed ID: 27558589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymyalgia rheumatica in biopsy proven giant cell arteritis does not constitute a different subset but differs from isolated polymyalgia rheumatica.
    González-Gay MA; García-Porrúa C; Vázquez-Caruncho M
    J Rheumatol; 1998 Sep; 25(9):1750-5. PubMed ID: 9733456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visual manifestations of giant cell arteritis. Trends and clinical spectrum in 161 patients.
    González-Gay MA; García-Porrúa C; Llorca J; Hajeer AH; Brañas F; Dababneh A; González-Louzao C; Rodriguez-Gil E; Rodríguez-Ledo P; Ollier WE
    Medicine (Baltimore); 2000 Sep; 79(5):283-92. PubMed ID: 11039076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors and predictive models of giant cell arteritis in polymyalgia rheumatica.
    Rodriguez-Valverde V; Sarabia JM; González-Gay MA; Figueroa M; Armona J; Blanco R; Fernández-Sueiro JL; Martínez-Taboada VM
    Am J Med; 1997 Apr; 102(4):331-6. PubMed ID: 9217613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Giant cell arteritis. Corticosteroids, temporal artery biopsy, and blindness.
    Weinberg DA; Savino PJ; Sergott RC; Bosley TM
    Arch Fam Med; 1994 Jul; 3(7):623-7. PubMed ID: 7921300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poor prognosis of visual outcome after visual loss from giant cell arteritis.
    Danesh-Meyer H; Savino PJ; Gamble GG
    Ophthalmology; 2005 Jun; 112(6):1098-103. PubMed ID: 15885780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of ischemic complications in patients with giant cell arteritis presenting with apparently isolated polymyalgia rheumatica: study of a series of 100 patients.
    Hernández-Rodríguez J; Font C; García-Martínez A; Espígol-Frigolé G; Sanmartí R; Cañete JD; Grau JM; Cid MC
    Medicine (Baltimore); 2007 Jul; 86(4):233-241. PubMed ID: 17632265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Slowly progressive vision loss in giant cell arteritis.
    Galor A; Lee MS
    Arch Ophthalmol; 2006 Mar; 124(3):416-8. PubMed ID: 16534064
    [No Abstract]   [Full Text] [Related]  

  • 12. Giant-cell arteritis, temporal arteritis and polymyalgia rheumatica. A retrospective study of 63 patients.
    Sorensen S; Lorenzen I
    Acta Med Scand; 1977; 201(3):207-13. PubMed ID: 848358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scalp necrosis with giant cell arteritis.
    Dudenhoefer EJ; Cornblath WT; Schatz MP
    Ophthalmology; 1998 Oct; 105(10):1875-8. PubMed ID: 9787357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Polymyalgia rheumatica and its treatment].
    Mumenthaler M
    Dtsch Med Wochenschr; 1974 Sep; 99(36):1774-5. PubMed ID: 4141305
    [No Abstract]   [Full Text] [Related]  

  • 15. Cotton-wool spots and the early diagnosis of giant cell arteritis.
    Melberg NS; Grand MG; Dieckert JP; Barney NP; Blumenkranz MS; Boone DE; Folk JC; Stransky TJ
    Ophthalmology; 1995 Nov; 102(11):1611-4. PubMed ID: 9098251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colour-duplex ultrasonography of the temporal and ophthalmic arteries in the diagnosis and follow-up of giant cell arteritis.
    Pérez López J; Solans Laqué R; Bosch Gil JA; Molina Cateriano C; Huguet Redecilla P; Vilardell Tarrés M
    Clin Exp Rheumatol; 2009; 27(1 Suppl 52):S77-82. PubMed ID: 19646351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary Care Vasculitis: Polymyalgia Rheumatica and Giant Cell Arteritis.
    Pioro MH
    Prim Care; 2018 Jun; 45(2):305-323. PubMed ID: 29759126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk Factors for Permanent Visual Loss in Biopsy-proven Giant Cell Arteritis: A Study of 339 Patients.
    Liozon E; Dalmay F; Lalloue F; Gondran G; Bezanahary H; Fauchais AL; Ly KH
    J Rheumatol; 2016 Jul; 43(7):1393-9. PubMed ID: 27134245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective study of 287 patients with polymyalgia rheumatica and temporal arteritis: clinical and laboratory manifestations at onset of disease and at the time of diagnosis.
    Myklebust G; Gran JT
    Br J Rheumatol; 1996 Nov; 35(11):1161-8. PubMed ID: 8948307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymyalgia rheumatica and temporal arteritis: managing older patients.
    Pereira M; Kaine JL
    Geriatrics; 1986 Jun; 41(6):54-5, 59-60, 63 passim. PubMed ID: 3710167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.